Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.

Humaidan, P; Chin, W; Rogoff, D; D'Hooghe, T; Longobardi, S; Hubbard, J; Schertz, J

Humaidan, P; Chin, W; Rogoff, D; D'Hooghe, T; Longobardi, S; Hubbard, J; Schertz, J.

Afiliação

Humaidan P; The Fertility Clinic, Skive Regional Hospital, Skive, Denmark.
Chin W; Faculty of Health, Aarhus University, Aarhus, Denmark.
Rogoff D; Global Biostatistics and Epidemiology, EMD Serono, Billerica, MA, USA, a business of Merck KGaA, Darmstadt, Germany.
D'Hooghe T; Global Clinical Development, EMD Serono Research and Development Institute, Billerica, MA, USA, a business of Merck KGaA, Darmstadt, Germany.
Longobardi S; Global Medical Affairs Fertility, Merck KGaA, Darmstadt, Germany.
Hubbard J; Global Medical Affairs Fertility, Merck KGaA, Darmstadt, Germany.
Schertz J; Global Clinical Development, EMD Serono Research and Development Institute, Billerica, MA, USA, a business of Merck KGaA, Darmstadt, Germany.

Hum Reprod ; 32(7): 1537-1538, 2017 07 01.

Article em En | MEDLINE | ID: mdl-28541398

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Hum Reprod Assunto da revista: MEDICINA REPRODUTIVA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google